Literature DB >> 21242740

Treatment of psychogenic polydipsia with acetazolamide: a report of 5 cases.

Shunsuke Takagi1, Yutaka Watanabe, Takefumi Imaoka, Masuhiro Sakata, Masako Watanabe.   

Abstract

OBJECTIVE: Psychogenic polydipsia occurs frequently in patients with chronic psychiatric illness and is often unmanageable. We herein report 5 patients in whom acetazolamide was trialed for this symptom.
METHODS: We encountered a case in which polydipsia improved with incidental administration of acetazolamide. We then used this treatment for 4 additional cases of treatment-resistant psychogenic polydipsia, some of which were accompanied by hyponatremia.
RESULTS: Acetazolamide improved polydipsia and/or hyponatremia in 4 of the 5 cases. This treatment was well tolerated and allowed 3 of the patients to permanently leave isolation.
CONCLUSION: Acetazolamide appears to have a beneficial effect in psychogenic polydipsia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21242740     DOI: 10.1097/WNF.0b013e318205070b

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

1.  Acetazolamide for Antipsychotic-Associated Weight Gain in Schizophrenia.

Authors:  Anil Kakunje; Ashwini Prabhu; Sindhu Priya Es; Ravichandra Karkal; Rahyanath K Pookoth; Rekha Pd
Journal:  J Clin Psychopharmacol       Date:  2018-12       Impact factor: 3.153

2.  Clinical characteristics and outcomes of hyponatraemia associated with oral water intake in adults: a systematic review.

Authors:  Nilofar Dorani; Miranda M Zhang; Gopala K Rangan; Lara Abu-Zarour; Ho Ching Lau; Alexandra Munt; Ashley N Chandra; Sayanthooran Saravanabavan; Anna Rangan; Jennifer Q J Zhang; Martin Howell; Annette Ty Wong
Journal:  BMJ Open       Date:  2021-12-09       Impact factor: 2.692

3.  Acetazolamide: Treatment of Psychogenic Polydipsia.

Authors:  Syed E Ahmed; Afaque H Khan
Journal:  Cureus       Date:  2017-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.